Quality of ADR reporting evaluated for remdesivir trials of COVID-19

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1827卷 / 1期
关键词：
D O I：
10.1007/s40278-020-84767-2
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：10 / 10
相关论文
共 50 条
  • [31] Assessing the reporting quality of randomized controlled trials on COVID-19 vaccines: a systematic review
    Zhang, Guanran
    Kuang, Sirui
    Zhang, Xiaoli
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [32] REMDESIVIR FOR THE TREATMENT OF COVID-19: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Musa, Arif
    Warbasse, Elizabeth
    Yousif, Jenna
    Baron, David
    Stevens, Susan
    Blodget, Emily
    Pendi, Kasim
    Hashemi, Areio
    Aly, Besma
    Khambati, Alisha
    Tajran, Jahan
    Paradela, Danielle Rangel
    Chen, Daniel H.
    Kamal, Khalid
    Kouyoumjian, Sarkis
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S157 - S158
  • [33] Remdesivir in treating hospitalized patients with COVID-19: A renewed review of clinical trials
    Wu, Zhenchao
    Han, Zhifei
    Liu, Beibei
    Shen, Ning
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [34] The place for remdesivir in COVID-19 treatment
    Young, Barnaby
    Tan, Thuan Tong
    Leo, Yee Sin
    LANCET INFECTIOUS DISEASES, 2021, 21 (01): : 20 - 21
  • [35] The role of remdesivir in COVID-19 infection
    Baombe, Janos P.
    EMERGENCY MEDICINE JOURNAL, 2020, 37 (08) : 522 - 523
  • [36] Remdesivir: From Ebola to COVID-19
    Santoro, M. Gabriella
    Carafoli, Ernesto
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 538 : 145 - 150
  • [37] Remdesivir for the treatment of COVID-19 in pregnancy
    Lampejo, Temi
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (07) : 4114 - 4119
  • [38] The safety of remdesivir for COVID-19 patients
    Chen, Hsien-Lin
    Chao, Chien-Ming
    Lai, Chih-Cheng
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (04) : 1910 - 1912
  • [39] Compassionate Use of Remdesivir in Covid-19
    Bonovas, Stefanos
    Piovani, Daniele
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25):
  • [40] Remdesivir, COVID-19, and Clinical Outcomes
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2022, 30 (02)
12345